Cover Image
市場調查報告書

美國的心臟病用侵入性、非侵入性診斷產品市場

U.S. Markets for Invasive and Noninvasive Diagnostic Cardiology Products

出版商 Medtech Insight 商品編碼 316327
出版日期 內容資訊 英文 264 pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的心臟病用侵入性、非侵入性診斷產品市場 U.S. Markets for Invasive and Noninvasive Diagnostic Cardiology Products
出版日期: 2014年10月01日 內容資訊: 英文 264 pages
簡介

美國的心臟病用侵入性、非侵襲診斷系統產品的整體銷售額於預測期間已3.4%的年複合成長率成長,預計從2013年的38億美元至2018年達到44億美元。

本報告提供美國的心臟病侵入性、非侵入性診斷產品市場相關分析、心臟疾病概要、治療方法、各產品的治療數、市場預測及競爭企業等彙整資料,為您概述為以下內容。

摘要整理

第1章 心臟疾病概要

  • 心臟、循環系
  • 主要的心臟疾病
    • 冠狀動脈心臟病(CHD)
    • 高血壓
    • 心肌病
    • 先天性心臟缺陷
    • 心律不整疾病
    • 心臟衰竭
  • 末稍血管疾病概要
  • 循環系的生物結構、生理功能
  • 末稍血管疾病的種類
    • 週邊動脈疾病(PAD)
    • 動脈瘤
    • 深部靜脈血栓症及肺栓塞
    • 慢性靜脈功能不全
  • 腦血管疾病概要
    • 心臟病發作

第2章 非侵入性診斷的心臟病治療、產品

  • 心電圖記錄法
  • 傳統X光掃描影像
  • CT
  • MRI
  • 核醫學/分子影像
  • 超音波診斷
  • 體外診斷模式

第3章 侵入性診斷的心臟病治療、產品

  • 血管造影法
  • 導管導引線的生理學性血管內狹窄診斷
  • 心臟超音波檢驗
  • 血管內超音波
  • 光同調斷層掃瞄(OCT)
  • 電生理學

附錄:企業清單

目錄
Product Code: A218

In the next decade, the number of people living in the United States (U.S.) with diseases/disorders of the heart and vascular system is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic conditions such as cardiovascular disease (CVD), diabetes, and obesity, which are exacerbated by unhealthful behaviors such as physical inactivity and tobacco smoking.

Diagnostic interventional cardiology procedures covered by the scope of this report include electrocardiography (ECG); non-invasive imaging systems including computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine, ultrasound, and X-ray; invasive diagnostic imaging systems including standard transcatheter coronary and peripheral angiography, electrophyiosology (EP) products, guidewire-based intravascular stenosis assessment, intracardiac echocardiography (ICE), intravascular ultrasound (IVUS), and optical coherence tomography (OCT); and in vitro diagnostics systems including cardiac markers, cholesterol testing products, and point-of-care/home coagulation monitoring systems. In the U.S. it is expected that the combined volume of these procedures will grow at a compound annual rate of 1.4% over the next half-decade, increasing from approximately 5.5 million in 2013 to an estimated 5.9 million in the year 2018. The total product sales for invasive and noninvasive diagnostic cardiology systems is expected to grow at a compound annual rate of 3.4% over the forecast period covered by this report, from approximately $3.8 billion in 2013 to an estimated $4.4 billion in the year 2018.

Table of Contents

EXECUTIVE SUMMARY

  • i. Total Invasive and Noninvasive Diagnostic Cardiology Products Market
  • ii. Methodology
  • Exhibit ES-1: Invasive Diagnostic Cardiology Products Market, Share by Segment, 2013 and 2018
  • Exhibit ES-2: Noninvasive Diagnostic Cardiology Products Market, Share by Segment, 2013 and 2018

1. CARDIOVASCULAR DISEASE OVERVIEW

  • 1.1. The Heart and Circulatory System
  • 1.2. Selected Heart Diseases/Disorders
    • 1.2.1. Coronary Heart Disease
      • 1.2.1.1. Atherosclerosis
      • 1.2.1.2. Angina Pectoris
      • 1.2.1.3. Myocardial Infarction
    • 1.2.2. Hypertension
      • 1.2.2.1. Systolic and Diastolic Pressures
      • 1.2.2.2. Prehypertension
    • 1.2.3. Cardiomyopathy
      • 1.2.3.1. Dilated Cardiomyopathy
      • 1.2.3.2. Hypertrophic Cardiomyopathy
      • 1.2.3.3. Restrictive Cardiomyopathy
    • 1.2.4. Congenital Heart Defects
      • 1.2.4.1. Ventricular Septal Defects
      • 1.2.4.2. Atrial Septal Defects
      • 1.2.4.3. Patent Ductus Arteriosus
    • 1.2.5. Cardiac Rhythm Disorders
      • 1.2.5.1. Bradycardia
      • 1.2.5.2. Supraventricular Tachycardia
        • 1.2.5.2.1. Atrial Fibrillation
      • 1.2.5.3. Ventricular Tachycardia
        • 1.2.5.3.1. Ventricular Fibrillation
    • 1.2.6. Heart Failure
      • 1.2.6.1. Disease Development
      • 1.2.6.2. Ejection Fraction Reduction
      • 1.2.6.3. Classification/Staging Systems
  • 1.3. Peripheral Vascular Disease Overview
  • 1.4. Anatomy and Physiology of the Circulatory System
  • 1.5. Types of Peripheral Vascular Disease
    • 1.5.1. Peripheral Artery Disease
      • 1.5.1.1. Etiology
      • 1.5.1.2. Epidemiology
    • 1.5.2. Aneurysm
      • 1.5.2.1. Etiology
      • 1.5.2.2. Epidemiology
    • 1.5.3. Deep Vein Thrombosis and Pulmonary Embolism
      • 1.5.3.1. Etiology
      • 1.5.3.2. Epidemiology
    • 1.5.4. Chronic Venous Insufficiency
      • 1.5.4.1. Etiology
      • 1.5.4.2. Epidemiology
  • 1.6. Cerebrovascular Disease Overview
    • 1.6.1. Stroke
      • 1.6.1.1. Etiology
      • 1.6.1.2. Epidemiology
  • Exhibit 1-1: Cross-Section Diagram of the Heart
  • Exhibit 1-2: Statistics for Selected Coronary Heart Disease Risk Factors
  • Exhibit 1-3: Standard Angina Pectoris Classification
  • Exhibit 1-4: Angina Pectoris, Selected Statistics
  • Exhibit 1-5: Clinical Classification of AMI
  • Exhibit 1-6: Myocardial Infarction, Selected Statistics
  • Exhibit 1-7: Percentage of Adults Who Have Been Told They Have High Blood Pressure, by State
  • Exhibit 1-8: Hypertension, Selected Statistics
  • Exhibit 1-9: Cardiomyopathy, Selected Statistics
  • Exhibit 1-10: Congenital Heart Defects, Selected Statistics
  • Exhibit 1-11: Summary, New York Heart Association Heart Failure Classification System
  • Exhibit 1-12: Summary, American College of Cardiology/American Heart Association Heart Failure Staging System
  • Exhibit 1-13: Heart Failure, Selected Statistics
  • Exhibit 1-14: Peripheral Artery Disease, Facts and Figures
  • Exhibit 1-15: Aortic Aneurysm, Facts and Figures
  • Exhibit 1-16: Deep Vein Thrombosis, Facts and Figures
  • Exhibit 1-17: Classification of Chronic Venous Insufficiency
  • Exhibit 1-18: Chronic Venous Insufficiency, Facts and Figures
  • Exhibit 1-19: 2014, Stroke, Selected Statistics

2. NONINVASIVE DIAGNOSTIC CARDIOLOGY PROCEDURES AND PRODUCTS

  • 2.1. Electrocardiography
    • 2.1.1. Resting Electrocardiography Examinations
    • 2.1.2. Exercise Stress Testing
    • 2.1.3. Ambulatory Electrocardiography
    • 2.1.4. Procedure Volumes
    • 2.1.5. Products
    • 2.1.6. Market Forecast
    • 2.1.7. Competitors
  • 2.2. Conventional X-Ray Imaging
    • 2.2.1. Computed Radiography and Digital Radiography
    • 2.2.2. General Radiology/Fluoroscopy
    • 2.2.3. Cardiovascular X-Ray Systems
    • 2.2.4. Procedure Volumes
    • 2.2.5. Products
    • 2.2.6. Market Forecast
    • 2.2.7. Competitors
  • 2.3. Computed Tomography
    • 2.3.1. Spiral Computed Tomography
    • 2.3.2. Multislice Computed Tomography
    • 2.3.3. Computed Tomography Angiography
    • 2.3.4. Perfusion Computed Tomography
    • 2.3.5. Cardiovascular-Related Applications of Computed Tomography
    • 2.3.6. Procedure Volumes
    • 2.3.7. Products
    • 2.3.8. Market Forecast
    • 2.3.9. Competitors
  • 2.4. Magnetic Resonance Imaging
    • 2.4.1. Magnetic Resonance Angiography
  • 2.4.1.1. Contrast-Enhanced Magnetic Resonance Angiography
  • 2.4.1.2. Phase-Contrast Magnetic Resonance Angiography
  • 2.4.1.3. Time-of-Flight Magnetic Resonance Angiography
    • 2.4.2. Functional Magnetic Resonance Imaging
    • 2.4.3. Proton Magnetic Resonance Spectroscopy
    • 2.4.4. Interventional Magnetic Resonance
    • 2.4.5. Cardiovascular-Related Applications of Magnetic Resonance Imaging Techniques
    • 2.4.6. Procedure Volumes
    • 2.4.7. Products
    • 2.4.8. Market Forecast
    • 2.4.9. Competitors
  • 2.5. Nuclear Medicine/Molecular Imaging
    • 2.5.1. Gamma Camera Imaging
    • 2.5.2. Positron Emission Tomography Scanner Imaging
    • 2.5.3. Fusion Imaging Techniques
    • 2.5.4. Cardiovascular-Related Applications of Nuclear Medicine Imaging
    • 2.5.5. Procedure Volumes
    • 2.5.6. Products
    • 2.5.7. Market Forecast
    • 2.5.8. Competitors
  • 2.6. Diagnostic Ultrasound
    • 2.6.1. Doppler Imaging
    • 2.6.2. Duplex Ultrasonography
    • 2.6.3. Echocardiography
    • 2.6.4. Cardiovascular-Related Applications of Ultrasound Imaging
    • 2.6.5. Procedure Volumes
    • 2.6.6. Products
    • 2.6.7. Market Forecast
    • 2.6.8. Competitors
  • 2.7. In Vitro Diagnostic Modalities
    • 2.7.1. Cholesterol Testing
    • 2.7.2. Cardiac Markers
      • 2.7.2.1. Creatine Kinase MB
      • 2.7.2.2. Myoglobin
      • 2.7.2.3. Cardiac Troponins
        • 2.7.2.3.1. Biochemical Markers in Point-of-Care Diagnostics of Heart Failure
    • 2.7.3. Coagulation Monitoring
      • 2.7.3.1. Activated Partial Thromboplastin Time Test
      • 2.7.3.2. Activated Clotting Time Test
      • 2.7.3.3. Bleeding Time Test
      • 2.7.3.4. Prothrombin Time Test
      • 2.7.3.5. Thrombin Clotting Time Test
    • 2.7.4. Procedure Volumes
    • 2.7.5. Products
    • 2.7.6. Market Forecast
    • 2.7.7. Competitors
  • Exhibit 2-1: Noninvasive Diagnostic Cardiology, Combined Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-2: Diagnostic Cardiology Products, Combined Market Forecast, 2013-2018
  • Exhibit 2-3: Electrocardiography, Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-4: Electrocardiography, Market Forecast, 2013-2018
  • Exhibit 2-5: 2013, Coronary Electrocardiography Devices Market, Share by Supplier
  • Exhibit 2-6: Coronary X-Ray, Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-7: Cardiac X-Ray Systems, Market Forecast, 2013-2018
  • Exhibit 2-8: 2013, Cardiac X-Ray Devices Market, Share by Supplier
  • Exhibit 2-9: Computed Tomography, Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-10: Computed Tomography Systems, Market Forecast, 2013-2018
  • Exhibit 2-11: 2013, Computed Tomography Devices Market, Share by Supplier
  • Exhibit 2-12: Magnetic Resonance Imaging, Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-13: Magnetic Resonance Imaging Systems, Market Forecast, 2013-2018
  • Exhibit 2-14: 2013, Magnetic Resonance Imaging Devices Market, Share by Supplier
  • Exhibit 2-15: Nuclear Medicine Imaging, Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-16: Nuclear Medicine Imaging Systems, Market Forecast, 2013-2018
  • Exhibit 2-17: 2013, Nuclear Medicine Imaging Devices Market, Share by Supplier
  • Exhibit 2-18: Diagnostic Ultrasound Imaging, Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-19: Diagnostic Ultrasound Imaging Systems, Market Forecast, 2013-2018
  • Exhibit 2-20: 2013, Diagnostic Ultrasound Imaging Devices Market, Share by Supplier
  • Exhibit 2-21: In Vitro Diagnostic Testing, Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-22: Cardiovascular In Vitro Diagnostic Testing, Market Forecast, 2013-2018
  • Exhibit 2-23: 2013, Cholesterol Testing Devices Market, Share by Supplier
  • Exhibit 2-24: 2013, Near-patient Cardiac Marker Testing Devices Market, Share by Supplier
  • Exhibit 2-25: 2013, Point-of-Care Coagulation Monitoring Devices Market, Share by Supplier

3. INVASIVE DIAGNOSTIC CARDIOLOGY PROCEDURES AND PRODUCTS

  • 3.1. Angiography
    • 3.1.1. Coronary Angiography
    • 3.1.2. Peripheral Angiography
      • 3.1.2.1. Peripheral Arterial Angiography
      • 3.1.2.2. Peripheral Venous Agiography
    • 3.1.3. Procedure Volumes
    • 3.1.4. Products
    • 3.1.5. Market Forecast
    • 3.1.6. Competitors
  • 3.2. Guidewire-Based Physiologic Intravascular Stenosis Assessment
    • 3.2.1. Technologies
    • 3.2.2. Procedure Volumes
    • 3.2.3. Products
    • 3.2.4. Market Forecast
    • 3.2.5. Competitors
  • 3.3. Intracardiac Echocardiography
    • 3.3.1. Technologies
    • 3.3.2. Procedure Volumes
    • 3.3.3. Products
    • 3.3.4. Market Forecast
    • 3.3.5. Competitors
  • 3.4. Intravascular Ultrasound
    • 3.4.1. Technologies
    • 3.4.2. Procedure Volumes
    • 3.4.3. Products
    • 3.4.4. Market Forecast
    • 3.4.5. Competitors
  • 3.5. Optical Coherence Tomography
    • 3.5.1. Products
    • 3.5.2. Procedure Volumes
    • 3.5.3. Market Forecast
    • 3.5.4. Competitors
  • 3.6. Electrophysiology
    • 3.6.1. Conventional Electrophysiology Studies
    • 3.6.2. Advanced Electrophysiology Mapping
    • 3.6.3. Products
    • 3.6.4. Procedure Volumes
    • 3.6.5. Market Forecast
    • 3.6.6. Competitors
  • Exhibit 3-1: Invasive Diagnostic Cardiology, Combined Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-2: Invasive Diagnostic Cardiology Products, Combined Market Forecast, 2013-2018
  • Exhibit 3-3: Coronary and Peripheral Angiography, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-4: Coronary Angiography Devices, Market Forecast, 2013-2018
  • Exhibit 3-5: 2013, Coronary Angiography Devices Market, Share by Supplier
  • Exhibit 3-6: 2013, Peripheral Angiography Devices Market, Share by Supplier
  • Exhibit 3-7: Guidewire-Based Physiologic Intravascular Stenosis Assessment, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-8: Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2013-2018
  • Exhibit 3-9: 2013, Physiologic Intravascular Stenosis Assessment Guidewire Systems Market, Share by Supplier
  • Exhibit 3-10: Intracardiac Echocardiography, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-11: Intracardiac Echocardiography Catheters, Market Forecast, 2013-2018
  • Exhibit 3-12: 2013, Intracardiac Echocardiography Catheters Market, Share by Supplier
  • Exhibit 3-13: Intravascular Ultrasound, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-14: Intravascular Ultrasound Products, Market Forecast, 2013-2018
  • Exhibit 3-15: 2013, Intravascular Ultrasound Products Market, Share by Supplier
  • Exhibit 3-16: Cardiovascular Optical Coherence Tomography, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-17: Cardiovascular Optical Coherence Tomography Systems, Market Forecast, 2013-2018
  • Exhibit 3-18: Electrophysiology, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-19: Electrophysiology Systems, Market Forecast, 2013-2018
  • Exhibit 3-20: 2013, Electrophysiology Products Market, Share by Supplier

APPENDIX: COMPANY LISTING

Back to Top